IDH1 and astrocytoma (excluding glioblastoma): The results also confirmed that application of the en-bloc technique (Supplementary Fig. 1) significantly contributed to patients’ PFS and OS, indicating that patients with astrocytoma, WHO grade 4, IDH mutation or glioblastomas could benefit from the application of en-bloc technique.